en

PRODUCT DETAIL

Orinox Neo

Code 2302D
MA number 69/0252/19-S
Product Form: aer nao 1x10 ml (fľ.HDPE s 3K sprej.pumpou)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 69 - OTORHINOLARYNGOLOGICA
ATC:
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AA Sympathomimetics, plain
R01AA07 Xylometazoline
Shelf life: 36
Container: bottle HDPE with nebuliser
Route of admin.: Nasal use
Prescription Status: Medicinal product not subject to medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 21.08.2019
Validity: 21.08.2024
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Orinox Neo_aer nao_08/2019_REG.docx  
SPC: SPC_Orinox Neo_aer nao_08/2019_REG.docx  
Safety feature No
Data update: 21.08.2019
eu-flag.png sk-flag.png